Targeted DNA/RNA Sequencing Market: How Is Liquid Biopsy Creating the Fastest-Growing Market Segment?
Liquid biopsy creating fastest-growing targeted sequencing segment — the commercial development of targeted next-generation sequencing of cell-free DNA (cfDNA) in blood — enabling non-invasive detection of somatic tumor mutations, copy number alterations, and gene fusions from circulating tumor DNA (ctDNA) shed by tumors into the bloodstream — creating a clinical testing...
0 Yorumlar 0 hisse senetleri 52 Views 0 önizleme